Glenview Trust’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.43M | Sell |
51,156
-423
| -0.8% | -$40.5K | 0.07% | 167 |
|
|
2025
Q4 | $4.95M | Buy |
51,579
+1,726
| +3% | +$168K | 0.08% | 157 |
|
|
2025
Q3 | $4.75M | Sell |
49,853
-2,996
| -6% | -$275K | 0.08% | 159 |
|
|
2025
Q2 | $4.61M | Sell |
52,849
-192
| -0.4% | -$16.3K | 0.08% | 156 |
|
|
2025
Q1 | $4.77M | Sell |
53,041
-1,055
| -2% | -$94.4K | 0.09% | 142 |
|
|
2024
Q4 | $4.32M | Buy |
54,096
+15
| +0% | +$1.3K | 0.08% | 149 |
|
|
2024
Q3 | $4.87M | Buy |
54,081
+384
| +0.7% | +$32.3K | 0.09% | 143 |
|
|
2024
Q2 | $4.23M | Sell |
53,697
-1,731
| -3% | -$142K | 0.09% | 140 |
|
|
2024
Q1 | $4.83M | Buy |
55,428
+2,658
| +5% | +$227K | 0.1% | 137 |
|
|
2023
Q4 | $4.35M | Sell |
52,770
-14,187
| -21% | -$1.08M | 0.11% | 135 |
|
|
2023
Q3 | $5.25M | Sell |
66,957
-1,868
| -3% | -$156K | 0.14% | 116 |
|
|
2023
Q2 | $6.06M | Sell |
68,825
-1,513
| -2% | -$130K | 0.17% | 106 |
|
|
2023
Q1 | $5.67M | Sell |
70,338
-1,498
| -2% | -$122K | 0.17% | 107 |
|
|
2022
Q4 | $5.58M | Sell |
71,836
-5,051
| -7% | -$409K | 0.19% | 106 |
|
|
2022
Q3 | $6.21M | Sell |
76,887
-12,569
| -14% | -$1.13M | 0.24% | 98 |
|
|
2022
Q2 | $8.03M | Sell |
89,456
-39,328
| -31% | -$3.98M | 0.3% | 87 |
|
|
2022
Q1 | $14.3M | Sell |
128,784
-72,471
| -36% | -$7.66M | 0.46% | 65 |
|
|
2021
Q4 | $20.8M | Sell |
201,255
-882
| -0.4% | -$102K | 0.69% | 46 |
|
|
2021
Q3 | $25.3M | Buy |
202,137
+3,082
| +2% | +$399K | 0.98% | 28 |
|
|
2021
Q2 | $24.7M | Buy |
199,055
+7,962
| +4% | +$1,000K | 0.95% | 29 |
|
|
2021
Q1 | $22.6M | Buy |
191,093
+5,014
| +3% | +$588K | 0.97% | 30 |
|
|
2020
Q4 | $21.8M | Buy |
186,079
+3,158
| +2% | +$348K | 1.01% | 29 |
|
|
2020
Q3 | $19M | Buy |
182,921
+13,659
| +8% | +$1.37M | 0.99% | 32 |
|
|
2020
Q2 | $15.5M | Buy |
169,262
+11,239
| +7% | +$1.08M | 0.88% | 34 |
|
|
2020
Q1 | $14.3M | Buy |
158,023
+10,724
| +7% | +$1.14M | 0.99% | 29 |
|
|
2019
Q4 | $16.7M | Buy |
147,299
+5,911
| +4% | +$649K | 0.93% | 34 |
|
|
2019
Q3 | $15.4M | Buy |
141,388
+6,435
| +5% | +$671K | 0.93% | 32 |
|
|
2019
Q2 | $13.1M | Buy |
134,953
+28,501
| +27% | +$2.6M | 0.82% | 39 |
|
|
2019
Q1 | $9.7M | Buy |
106,452
+49,890
| +88% | +$4.47M | 0.62% | 50 |
|
|
2018
Q4 | $5.14M | Buy |
56,562
+185
| +0.3% | +$17.3K | 0.38% | 78 |
|
|
2018
Q3 | $5.55M | Sell |
56,377
-1,575
| -3% | -$146K | 0.35% | 90 |
|
|
2018
Q2 | $4.96M | Sell |
57,952
-1,045
| -2% | -$87.3K | 0.37% | 84 |
|
|
2018
Q1 | $4.73M | Sell |
58,997
-770
| -1% | -$63.5K | 0.33% | 93 |
|
|
2017
Q4 | $4.83M | Buy |
59,767
+776
| +1% | +$62.1K | 0.33% | 90 |
|
|
2017
Q3 | $4.59M | Sell |
58,991
-783
| -1% | -$65K | 0.34% | 92 |
|
|
2017
Q2 | $5.3M | Sell |
59,774
-1,041
| -2% | -$87.8K | 0.41% | 84 |
|
|
2017
Q1 | $4.9M | Sell |
60,815
-2,006
| -3% | -$157K | 0.39% | 84 |
|
|
2016
Q4 | $4.47M | Buy |
+62,821
| New | +$4.94M | 0.37% | 83 |
|
|
2015
Q4 | $10.4M | Buy |
+135,616
| New | +$10.2M | 1.08% | 32 |
|
|
2014
Q4 | $10.5M | Buy |
+145,305
| New | +$10.1M | 1.12% | 35 |
|
|
2013
Q4 | $9.37M | Buy |
+163,215
| New | +$9.25M | 1.08% | 37 |
|
Other funds holding MDT
VCM
VPM
Glenview Trust's MDT Position: Q1 2026 in Review
Glenview Trust reduced its Medtronic (MDT) stake by 0.82% in Q1 2026, selling an estimated $40.5K and leaving 51,156 shares worth $4.43M. The position accounts for 0.07% of the portfolio, ranked #167.
Glenview Trust first reported a position in MDT in Q4 2013 and has held it in 41 quarters since. The position peaked at $25.3M in Q3 2021. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Glenview Trust held 51,156 shares of Medtronic worth $4.43M as of Q1 2026.
- Glenview Trust sold 423 Medtronic shares in Q1 2026, an estimated $40.5K.
- Medtronic made up 0.07% of Glenview Trust's portfolio in Q1 2026, its #167 holding.
- Glenview Trust first reported a position in Medtronic in Q4 2013 and has held it in 41 quarters since.
- Glenview Trust's Medtronic position peaked at $25.3M in Q3 2021.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.